Regulatory

Part:BBa_K1699001:Design

Designed by: Emil Ruvinov   Group: iGEM15_BGU_Israel   (2015-08-09)
Revision as of 11:36, 13 September 2015 by Emilr78 (Talk | contribs) (→‎Design Notes)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Human short TERT promoter


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Designed using Benchling to meet registry standards. Synthesized by Syntezza Biosience. Cloned into pSB1C3 using EcoRI and PstI restriction sites.

Source

Human genomic DNA sequence. Based on: Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers. Gu J, Kagawa S, Takakura M, Kyo S, Inoue M, Roth JA, Fang B. Cancer Res. 2000 Oct 1;60(19):5359-64. http://www.ncbi.nlm.nih.gov/pubmed/11034071